Sally Del Principe

Corporate Officer/Principal presso Lupton del Principe Associates Ltd.

67 anni

Commercial Services

Profilo

Sally Del Principe is currently a Partner at Lupton del Principe Associates Ltd.
where she has worked since 1992.
Previously, she worked as the Chief Financial Officer at HIV-VAC, Inc. from 2001 to 2010.

Posizioni attive di Sally Del Principe

Società	Posizione	Inizio
Lupton del Principe Associates Ltd.	Corporate Officer/Principal	09/04/2010

Tutte le posizioni attive di Sally Del Principe

Precedenti posizioni note di Sally Del Principe

Società	Posizione	Fine
HIV-VAC, Inc. HIV-VAC, Inc. Miscellaneous Commercial ServicesCommercial Services HIV-VAC, Inc. develops and markets proposed vaccine designed to combat HIV/AIDS. This proposed vaccine, which is called NFU.Ac.HIV, was developed by Dr. Gordon Skinner, director of research, through the University of Birmingham, in the U.K. The proposed vaccine was licensed to Intracell Vaccines Limited from the University of Birmingham. The company was founded in 1997 and is headquartered in Ontario, CA.	Direttore Finanziario/CFO	28/10/2010

Vedi nel dettaglio l'esperienza di Sally Del Principe

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Sally Del Principe

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
HIV-VAC, Inc. HIV-VAC, Inc. Miscellaneous Commercial ServicesCommercial Services HIV-VAC, Inc. develops and markets proposed vaccine designed to combat HIV/AIDS. This proposed vaccine, which is called NFU.Ac.HIV, was developed by Dr. Gordon Skinner, director of research, through the University of Birmingham, in the U.K. The proposed vaccine was licensed to Intracell Vaccines Limited from the University of Birmingham. The company was founded in 1997 and is headquartered in Ontario, CA.	Commercial Services
Lupton del Principe Associates Ltd.